Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
86
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

169
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
169
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Antiphospholipid antibodies and cardiovascular thrombosis.

Nature reviews. Cardiology·2026
Same author

Molecular Stratification of Antiphospholipid Syndrome Through Integrative Analysis of the Whole-Blood RNA Transcriptome.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Liver Metastases License Neutrophils through IL1 to Potentiate Cancer Progression.

Cancer immunology research·2025
Same author

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target.

Blood advances·2025
Same author

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.

Arthritis care & research·2025
Same author

Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities.

Arthritis & rheumatology (Hoboken, N.J.)·2025

相关实验视频

Updated: Jun 27, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K

重新思考抗脂综合征,以指导未来的管理和研究.

Jason S Knight1, Doruk Erkan2

  • 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.

Nature reviews. Rheumatology
|May 3, 2024
PubMed
概括

抗脂综合征 (APS) 管理需要精细化,超出一种适合所有人的方法. 新的分类标准为APS患者提供了分类类型和个性化治疗策略的机会.

科学领域:

  • 类风湿病学 类风湿病学
  • 免疫学 免疫学 免疫学
  • 血液学 血液学 血液学

背景情况:

  • 抗脂综合征 (APS) 的特点是具有抗脂抗体 (aPL) 个体的血栓,非血栓和产科事件.
  • 目前的APS临床管理依赖于普遍的"一刀切"战略,受限于前性,受控研究的稀缺性.
  • 尽管在表型化方面取得了进展,但在APS中仍然需要更个性化的管理方法.

研究的目的:

  • 突出目前APS管理策略的局限性.
  • 引入2023年ACR-EULAR APS分类标准作为变革的催化剂.
  • 倡导基于病理生理学和未满足的临床需求的亚表型化APS.

主要方法:

  • 审查关于APS临床表现和管理的现有文献.
  • 对新发布的2023年ACR-EULAR APS分类标准的影响分析.
  • 根据病理生理学和临床需求,讨论未来的研究方向.

主要成果:

  • 目前的"一个尺寸适合所有"的APS管理方法是不理想的.
  • 2023年ACR-EULAR APS分类标准为重新考虑APS提供了基础.
  • 基于病理生理学的新方法可以使APS的亚表型化成为可能.

更多相关视频

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

623
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K

相关实验视频

Last Updated: Jun 27, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.6K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

623
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.0K

结论:

  • 2023年ACR-EULAR APS分类标准促进了理解和管理APS的范式转变.
  • 未来的APS研究应该专注于亚表型化和解决未满足的临床需求.
  • 个性化管理策略对于改善APS患者的治疗结果至关重要.